Product Description
Since last manyyears Saintroy Lifescience is leading manufacture, export and supplierofAzacitidine for Injectionfrom Surat, Gujarat, India. Azacitidine forInjection used in the treatment of myelodysplastic syndrome.
Tags: Azacitidine for Injection manufacturer, Azacitidine forInjection exporter, Azacitidine for Injection supplier, and Azacitidine forInjection, whogmp approved Azacitidine for Injection manufacturer and supplier,Azacitidine for Injection distributor, Azacitidine for Injection shipper, Azacitidine ForInjection 100 mg Azacitidine for Injection 100 mg supplier,Azacitidine for Injection100 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility inGujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Azacitidine forInjection export to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Therapeutic Indication and EfficacyAzacitidine for Injection is indicated for patients with myelodysplastic syndromes, offering an established option to help correct abnormal blood cell formation. By inhibiting abnormal cell growth, it can help reduce the need for transfusions and improve overall blood health. Patients should always consult with a specialized physician for appropriate use and monitoring.
Proper Dosage Form and AdministrationThis medication is provided as a sterile powder and must be reconstituted with sterile water for injection just prior to use. It is administered via subcutaneous or intravenous injection under strict medical supervision. Patients must not attempt to self-administer and should receive each dose in a suitable healthcare setting.
Safe Handling and Storage GuidelinesEnsure the vials of Azacitidine for Injection are kept in a cool, dry place to maintain efficacy. Only qualified medical personnel should handle reconstitution and administration. Discard any unused portion after single use. Always check the expiration date before use to guarantee safety and effectiveness.
FAQ's of Azacitidine For Injection:
Q: How is Azacitidine for Injection administered?
A: This medication is administered by a healthcare professional as a subcutaneous or intravenous injection after reconstituting the powder with sterile water for injection. Self-administration is not recommended.
Q: What is the process for preparing the injection?
A: A qualified healthcare provider will reconstitute each single-dose vial with the appropriate amount of sterile water for injection, ensuring the powder dissolves fully before administration. Precise preparation ensures accurate dosing and patient safety.
Q: When should the medication be given to patients?
A: Azacitidine is prescribed specifically for the treatment of myelodysplastic syndromes and should be administered according to a schedule determined by the treating physician, based on individual patient needs and response.
Q: Where should Azacitidine for Injection be stored before use?
A: Store the vials in a cool, dry place away from direct sunlight. Proper storage preserves the stability and effectiveness of the medicine until it is reconstituted and used.
Q: What are the main benefits of using Azacitidine for Injection?
A: The medication helps manage myelodysplastic syndromes by improving blood cell production, reducing symptoms, and potentially decreasing the need for blood transfusions, thereby enhancing patient quality of life.
Q: Who should supervise the use of this medication?
A: Only a qualified physician experienced with antineoplastic agents should oversee the preparation, administration, and monitoring of Azacitidine for Injection to ensure safe and effective treatment.